Chugai Pharmaceutical Co Ltd ADR (CHGCY)

Currency in USD
24.69
-0.13(-0.52%)
Closed·
After Hours
24.690.00(0.00%)
·

CHGCY Financial Summary

Key Ratios

P/E Ratio30.96
Price/Book6
Debt / Equity0.57%
Return on Equity21.16%
Dividend Yield0.00%
EBITDA573.67B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 240.31%
Dividend Yield
-
Industry Median 2.83%
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
59.04 / --
Revenue / Forecast
290.01B / --
EPS Revisions
Last 90 days

FAQ

What were Chugai Pharma ADR's earnings for the latest quarter?

The Chugai Pharma ADR EPS (TTM) is 240.31. Chugai Pharma ADR reported sales of 290,005.00, net income of 97,155.00, and EPS of 59.04 for the latest quarter.

What was Chugai Pharma ADR's net income for the latest quarter?

Chugai Pharma ADR's net income for the latest quarter was 97,155.00.

How did Chugai Pharma ADR's performance compare year-over-year in the latest quarter?

The company's revenue moved from 288,459.00 in the previous quarter to 290,005.00 in the latest quarter, and net income moved from 97,234.00 to 97,155.00 compared to the previous quarter.

What is Chugai Pharma ADR's net profit margin on a TTM basis?

Chugai Pharma ADR's trailing twelve months (TTM) net profit margin is 33.09%.

How does Chugai Pharma ADR's debt to equity ratio compare to industry standards?

Chugai Pharma ADR's total debt-to-equity ratio is 0.57%.

What is Chugai Pharma ADR's return on investment on a TTM basis?

Chugai Pharma ADR's trailing twelve months (TTM) return on investment (ROI) is 21.16%.

Did Chugai Pharma ADR gain or lose cash last quarter?

In the latest quarter, Chugai Pharma ADR's net change in cash was 73,669.00 million.

What were Chugai Pharma ADR's total assets and liabilities in the latest quarter?

As of the latest quarter, Chugai Pharma ADR reported total assets of 2,278,347.00 million and total liabilities of 268,276.00 million.

How has Chugai Pharma ADR's total revenue grown this year?

Chugai Pharma ADR's total revenue was 288,459.00 in the previous quarter and 290,005.00 in the latest quarter.

What is Chugai Pharma ADR's gross margin on a TTM basis?

Chugai Pharma ADR's trailing twelve months (TTM) gross margin is 70.37%.

What was Chugai Pharma ADR's revenue per share for the latest quarter?

Chugai Pharma ADR's revenue per share for the latest quarter was 43.82.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.